Wang X - Search Results

1

miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis.

Yu ZH, Chen ZH, Zhou GL, Zhou XJ, Ma HY, Yu Y, Wang X, Cao XC. Yu ZH, et al. Among authors: wang x. Thorac Cancer. 2022 Nov;13(21):2992-3000. doi: 10.1111/1759-7714.14648. Epub 2022 Sep 13. Thorac Cancer. 2022. PMID: 36100919 Free PMC article.

2

miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.

Yu Y, Luo W, Yang ZJ, Chi JR, Li YR, Ding Y, Ge J, Wang X, Cao XC. Yu Y, et al. Among authors: wang x. Mol Cancer. 2018 Mar 6;17(1):70. doi: 10.1186/s12943-018-0818-9. Mol Cancer. 2018. PMID: 29510731 Free PMC article.

3

Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.

Yu Y, Zhao Y, Sun XH, Ge J, Zhang B, Wang X, Cao XC. Yu Y, et al. Among authors: wang x. Oncotarget. 2015 Oct 27;6(33):34423-36. doi: 10.18632/oncotarget.5406. Oncotarget. 2015. PMID: 26460733 Free PMC article.

4

Serum deprivation response inhibits breast cancer progression by blocking transforming growth factor-β signaling.

Tian Y, Yu Y, Hou LK, Chi JR, Mao JF, Xia L, Wang X, Wang P, Cao XC. Tian Y, et al. Among authors: wang x, wang p. Cancer Sci. 2016 Mar;107(3):274-80. doi: 10.1111/cas.12879. Epub 2016 Feb 13. Cancer Sci. 2016. PMID: 26749136 Free PMC article.

5

miR-142-3p inhibits cancer cell proliferation by targeting CDC25C.

Cao XC, Yu Y, Hou LK, Sun XH, Ge J, Zhang B, Wang X. Cao XC, et al. Among authors: wang x. Cell Prolif. 2016 Feb;49(1):58-68. doi: 10.1111/cpr.12235. Epub 2016 Jan 25. Cell Prolif. 2016. PMID: 26805039 Free PMC article.

6

miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.

Hou LK, Yu Y, Xie YG, Wang J, Mao JF, Zhang B, Wang X, Cao XC. Hou LK, et al. Among authors: wang x, wang j. Oncotarget. 2016 May 3;7(18):26016-26. doi: 10.18632/oncotarget.8421. Oncotarget. 2016. PMID: 27036021 Free PMC article.

7

miR-410-3p suppresses breast cancer progression by targeting Snail.

Zhang YF, Yu Y, Song WZ, Zhang RM, Jin S, Bai JW, Kang HB, Wang X, Cao XC. Zhang YF, et al. Among authors: wang x. Oncol Rep. 2016 Jul;36(1):480-6. doi: 10.3892/or.2016.4828. Epub 2016 May 23. Oncol Rep. 2016. PMID: 27221455

8

FYN promotes breast cancer progression through epithelial-mesenchymal transition.

Xie YG, Yu Y, Hou LK, Wang X, Zhang B, Cao XC. Xie YG, et al. Among authors: wang x. Oncol Rep. 2016 Aug;36(2):1000-6. doi: 10.3892/or.2016.4894. Epub 2016 Jun 22. Oncol Rep. 2016. PMID: 27349276

9

The prognostic value of node status in different breast cancer subtypes.

Yang ZJ, Yu Y, Hou XW, Chi JR, Ge J, Wang X, Cao XC. Yang ZJ, et al. Among authors: wang x. Oncotarget. 2017 Jan 17;8(3):4563-4571. doi: 10.18632/oncotarget.13943. Oncotarget. 2017. PMID: 27999188 Free PMC article.

10

Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer.

Ge J, Yu Y, Xin F, Yang ZJ, Zhao HM, Wang X, Tong ZS, Cao XC. Ge J, et al. Among authors: wang x. Cancer Sci. 2017 Apr;108(4):604-611. doi: 10.1111/cas.13180. Epub 2017 Apr 12. Cancer Sci. 2017. PMID: 28403546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,617 results

Search Page

Filters